FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Track all the latest updates and news of Bafna Pharmaceuticals IPO.
July 16, 2024 8:11:00 PM
J.P. Morgan, Goldman Sachs & Co. and BofA Securities are lead book-running managers for the IPO. Deutsche Bank Securities, Wells Fargo Securities, Mizuho, RBC Capital Markets and Truist Securities are ...
Published by : The Business JournalsJuly 20, 2024 12:20:00 PM
A handful of IPOs priced this past week, led by three sizable names. One large issuer joined both the pipeline and the calendar - Chile-based LATAM Airlines Group.
Published by : Seeking AlphaJuly 8, 2024 9:58:00 PM
Those who have invested in Emcure Pharmaceuticals IPO can check their allotment status online via the official websites of BSE and issue�s registrar. Emure Pharmaceuticals IPO is set to release ...
Published by : Hindustan TimesJuly 2, 2024 1:43:05 PM
E mcure Pharmaceuticals is set to open its initial public offering (IPO) for subscription on Wednesday, July 3. Before the listing, the company's shares were trading at a premium of Rs 265 in the ...
Published by : Times Now on MSNJuly 3, 2024 2:12:00 PM
Shark Tank fame Namita Thapar likely to make around Rs 127 crore through Emcure Pharmaceuticals IPO Emcure Pharmaceuticals' FY 2024 revenue grew by 11% to Rs 6,658 crore, with profits at Rs 527 crore.
Published by : IndiatimesJuly 4, 2024 12:39:00 AM
Emcure Pharmaceuticals IPO price band has been set in the range of ?960 to ?1,008 per equity share of the face value of ?10. (https://www.emcure.com/) Emcure ...
Published by : MintJuly 10, 2024 1:08:00 AM
Emcure Pharmaceuticals IPO listing: Ahead of the listing, Emcure Pharma IPO GMP is +352 which indicates that the company's share price was trading at a premium. Emcure Pharmaceuticals IPO listing ...
Published by : Hindustan TimesJuly 3, 2024 3:50:00 PM
The initial public offering of Emcure Pharmaceuticals Ltd begins for subscriptions today July 3, 2024. The IPO, backed by Bain Capital, has a price band set between ?960 and ?1,008 per share ...
Published by : India InfolineJuly 4, 2024 3:56:00 PM
Emcure Pharmaceuticals Ltd�s IPO, opened on July 3. The ?1,952-Crore IPO closes on July 5 and has received an overall subscription of 2.48 times at the time of writing on July 4, 2024 at 12:18 ...
Published by : India InfolineJuly 9, 2024 11:28:00 PM
Emcure Pharmaceuticals IPO listing date has been scheduled for tomorrow (Wednesday, July 10). (https://www.emcure.com/) Emcure Pharmaceuticals IPO listing date has ...
Published by : MintBafna Pharmaceuticals Ltd IPO Listing Info:
IPO Listing Date: Friday, June 27, 2008
BSE Script Code: 532989
Listing in: B Group of securities
ISIN: INE878I01014
Issue Price: Rs. 40/-
Face Value: Rs 10/- Per Equity Share
IPO Allotment Status is now available online for Bafna Pharmaceuticals Ltd IPO.
Issue was fixed price and will only list on BSE. Listing date will be available soon.
Incorporated in 1995, Bafna Pharmaceuticals Limited is engaged in the business of manufacturing pharmaceutical formulations of Betalactum and Non Betalactum products.
Bafna Pharmaceuticals Limited is entering in the capital markets with an initial public offering, IPO of 64,00,000 Equity Shares for cash, at the premium of Rs 30.
The price band for the issue has been fixed at Rs. 40/- for equity share of Rs. 10/-. The issue opens on May 27, 2008, and closes for subscription on May 30, 2008. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE).
The Bafna Pharmaceuticals IPO is proposed to open on May 27, 2008. The IPO application ends on May 30, 2008.
Retail investors can apply in the retail or non-institutional investor category from May 27, 2008 to May 30, 2008. The Bafna Pharmaceuticals IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Bafna Pharmaceuticals IPO will open for subscription on May 27, 2008. The public issue will close on May 30, 2008.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|